Childhood malignant diseases: which is the carnitine's role?
Rogalidou
Maria E
ME
Paediatrics Department, University Hospital of Heraklion, Crete, Greece. rogalidu@yahoo.com
Stiakaki
Eftichia
E
Evangeliou
Athanasios
A
Kalmanti
Maria
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002331:Carnitine / Q000008:administration & dosage / Q000378:metabolism*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*
D002331:Carnitine